Please login to the form below

key opinion leaders

This page shows the latest key opinion leaders news and features for those working in and with pharma, biotech and healthcare.

ACPs to lead gene therapies in haemophilia market growth

GlobalData found that key opinion leaders in the eight major markets (the US, France, Germany, Italy, Spain, UK, Japan, and China) are highly optimistic about these therapies and agree that they

Latest news

GSK to reverse ‘no KOLs’ policy, admitting it has hit marketing

Company seeking to revive lacklustre marketing performance. GlaxoSmithKline is to reverse its ban on paying healthcare professionals and key opinion leaders (KOLs), admitting that the policy has hit awareness of its ... Nevertheless, GSK will be keen to
A unique ecosystem

How life science and healthcare clusters are driving innovation. Innovation is a key driver for economic growth in the 21st century. ... Start-ups from either cluster could attend B2B meetings and presentations by key opinion leaders with the objective
Harnessing the unrivalled power of key opinion leaders

Engaging early. Engaging the right key opinion leaders (KOLs) at an early stage in the life cycle, and utilising their expertise and influence, is key to securing timely and positive data ... Also, working with KOLs in each of your target markets is key
Spink wins gastroenterology society account

ESPGHAN’s annual congress is attended by over 4, 000 delegates and globally attracts key opinion leaders in the field of paediatric gastroenterology, hepatology and nutrition. ... Managing relations with the medical trade and global press, Spink will
Riding the wave of digital disruption

And the key to thriving in this brave new world lies with the changing needs of the healthcare professional. ... Specifically, Gorini's team in Italy is working to use this customer data to tailor interactions with key opinion leaders to follow their

More from news
Approximately 0 fully matching, plus 92 partially matching documents found.

Latest Intelligence

The ‘blueprint’ for MSL success is changing

MSLs are active in the pre-launch phase, promoting disease awareness and engagement with Key Opinion Leaders. ... Key performance indicators are aligned to the framework, and competencies help to consistently deliver vital components of the SMOs.
The power of high-value, highly relevant content to support clinical decisions

The year- long digital campaign included a range of materials – including educational articles, quizzes, emails and banners – featuring relevant Key Opinion Leaders. ... The gap is made credible because it is based on real HCP engagement –
Breaking free

Similarly, identity can be key; if a new behaviour leads to a more positive self-image, behaviour is again reinforced over time. ... Digital interactions – through personalised, targeted content – can help. We’ve seen numerous examples of this,
Breaking from tradition - social media at medical congresses

Consider the role of partners, whether Digital Opinion Leaders (those HCPs who are actively influencing the conversation within a therapy area), research organisations, advocacy groups or, where appropriate, expert patients, for ... 4. Provide a platform
Immunotherapy combination trials Q&A

In order to ensure efficient spend and effort, these key criteria should be met positively and, most importantly, only those sites that have the capabilities to deliver IO trials, as well ... Patient referral networks, recruitment materials and scientific

More from intelligence
Approximately 3 fully matching, plus 34 partially matching documents found.

Latest appointments

Bone Therapeutics strengthens clinical development team

In addition to his specific experience with cell therapy products, Dr Forte has extensive experience in interacting with regulatory bodies and establishing strong relationships with investigators and key opinion leaders.”.
Biomunex appoints scientific and strategic advisors

Dr Pierre-Emmanuel Gerard, chief executive officer at Biomunex, said: “We are very pleased to welcome Dr Amigorena and Dr Grabulovski as key advisors. ... As international key opinion leaders they will play an instrumental role as we advance our first
ABPI appoints Pfizer’s Colette Goldrick as first Northern Ireland director

Will develop relationships with key opinion leaders in region. T he Association of the British Pharmaceutical Industry (ABPI) has appointed Pfizer Europe's f ormer head of head of public affairs ... A native of Northern Ireland, Goldrick will be tasked

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Diagnosing MS: are we getting it right?

This is even more important when some key opinion leaders within neurology advocate the need to treat early with efficacious drugs for the best chance to delay progression. ... This is a key diagnostic tool in MS, without which an official diagnosis is
Good data is nothing without advocacy

These respected key opinion leaders (KOLs) have a strong voice and can provide invaluable advice to HCPs at meetings and congresses, including giving feedback via advisory boards. ... Recognition and relationships:. Brand/company recognition. Overall
How can pharma engage with key stakeholders on NHS service transformation?

Industry should also refine its proposition for transformation leads, medicines management staff and other key opinion leaders (KOLs), who may have different drivers and priorities. . ... Pharma can also take a lead in facilitating discussions between
Medopad: the up and coming unicorn transforming remote patient monitoring

a key driver in this growth. ... The company works with patient groups, key opinion leaders and hospitals to learn what clinicians and patients need from a remote patient monitoring service.
Developing advocacy in the pharmaceutical industry.

In fact, having open and honest relationships with your key opinion leaders (KOLs) is crucial to launching and growing a successful brand and is an important element of any business plan. ... The development of a charter is an elegant way of doing this